Proteinase Inhibitors Block Formation of Pemphigus Acantholysis in Experimental Models of Neonatal Mice and Skin Explants: Effects of Synthetic and Plasma Proteinase Inhibitors on Pemphigus Acantholysis

This publication has 17 references indexed in Scilit:

• Involvement of Urokinase-Type Plasminogen Activator in Acantholysis Induced by Pemphigus IgG
  Journal of Investigative Dermatology, 1987
• Pathogenesis of Autoimmunity in Pemphigus
  Annual Review of Immunology, 1985
• Experimentally Induced Pemphigus Vulgaris in Neonatal BALB/c Mice: A Time-Course Study of Clinical, Immunologic, Ultrastructural, and Cytochemical Changes
  Journal of Investigative Dermatology, 1985
• Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.
  The Journal of Experimental Medicine, 1983
• The Pathogenic Mechanisms of Blister Formation in Bullous Pemphigoid
  Journal of Investigative Dermatology, 1982
• Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG from Patients with the Disease
  New England Journal of Medicine, 1982
• A SENSITIVE, COUPLED ASSAY FOR PLASMINOGEN ACTIVATOR USING A THIOL ESTER SUBSTRATE FOR PLASMIN*
  Annals of the New York Academy of Sciences, 1981
• The Pathogenic Role of Pemphigus Antibodies and Proteinase in Epidermal Acantholysis
  Journal of Investigative Dermatology, 1981
• Production Of Epidermal Acantholysis In Normal Human Skin In Vitro By The Igg Fraction From Pemphigus Serum
  Journal of Investigative Dermatology, 1976
• Inhibitory effects of ω-guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin
  Biochimica et Biophysica Acta (BBA) - Enzymology, 1972